Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
Sign Up to like & getrecommendations! Published in 2020 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2020.102969
Abstract: Abstract Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular weight heparin (LMWH) on mortality in COVID-19. In part,… read more here.
Keywords: covid patients; anticoagulant mechanisms; non anticoagulant; covid ... See more keywords